MAP2K2 and RASopathy: On these bases, theseauthors proposed that haploinsufficiency of MAP2K2/MEK2 "appears to bea new model of a RASopathy, where a deletion of one of the components of the pathway,MEK2, results in a RASopathy-like phenotype" (Nowaczyket al., 2014).